Story
Humana Stock Surges After Barclays Upgrade on Medicare Ratings Optimism
Summary
Shares of health insurer Humana Inc. jumped Friday after Barclays upgraded the stock to Overweight, citing increased confidence in a crucial rebound for the company's Medicare Advantage Star ratings.
Humana Inc. (NYSE:HUM) shares surged more than 6% on Friday following an upgrade from Barclays, which expressed growing optimism about the health insurer's upcoming Medicare Advantage Star ratings. The stock saw its largest intraday gain since June, climbing as much as 9% during the session.
Analyst Upgrade Drives Rally
Barclays analyst Andrew Mok upgraded Humana to Overweight from Equal-Weight and significantly raised the firm's price target on the stock to $515 from a previous $407. The upgrade was issued ahead of a key catalyst for the company: the release of new Medicare Star ratings.
Mok cited "an increasingly constructive view that the company will flip several contracts to bonus status," according to the analyst note. This improved outlook reflects a stronger conviction in Humana's ability to secure higher ratings, which are critical for profitability in the Medicare Advantage market.
Focus on Key Contract
AdThe upgrade centers on the potential for an improved rating for Humana's H5216 contract, which covers 2.4 million members. Barclays now assigns a 75% probability that this specific contract will achieve the necessary rating to qualify for bonus payments.
The financial implications of this rating change are substantial. According to Barclays' analysis, a successful upgrade for the H5216 contract represents:
- Approximately $1.5 billion in earnings before interest and taxes (EBIT).
- An estimated $9 in earnings per share (EPS).
The upcoming ratings, expected around October 8, are considered a critical component of Humana's long-term financial targets. The analyst noted that the company is entering this year's rating cycle in a much stronger position than it was a year ago.
Read next
More on Stocks
SK Hynix Unit Solidigm Reportedly Eyes IPO at Potential $150 Billion Valuation
The U.S.-based memory chip subsidiary of SK Hynix is exploring a public listing that could raise $15 billion and become one of the largest semiconductor IPOs in U.S. history, according to a media report.
AMD Joins Trillion-Dollar Club as AI Bets Fuel Weekly Stock Moves
Advanced Micro Devices crossed a $1 trillion market capitalization this week, while Meta and Moderna also saw significant gains. Oracle shares declined following a report on potential delays at a key data center project.
Investors Eye Dallas Fed Index, Treasury Auctions to Start Week
Market participants will monitor regional manufacturing data from the Dallas Federal Reserve and the results of two Treasury bill auctions on Monday. Remarks from Richmond Fed President Thomas Barkin are also scheduled, offering potential insights into monetary policy.
Revvity Sees Large Bullish Options Bet Targeting $170 Strike for 2026
Unusual options activity in Revvity (RVTY) was observed with a call-to-put ratio of nearly 156-to-1, driven by a single large trade on out-of-the-money calls expiring in November 2026.